Both in Biotechnology
BioStem Technologies vs Metagenomi Therapeutics
Over the past year BSEM returned −73.3% and MGX returned −31.9%; their daily moves had a correlation of 0.15.
BSEM −73.3% MGX −31.9%Growth of $1, one year, split-adjusted
| Metric | BSEM | MGX |
|---|---|---|
| Price | $1.15 | $0.7900 |
| Market cap | $21.5M | $29.8M |
| Today | 0.00% | +3.95% |
| 1 month | −53.4% | −23.3% |
| 6 months | — | −44.8% |
| Year to date | — | −51.2% |
| 1 year | — | −67.4% |
| Revenue growth (YoY) | — | −103.0% |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | 2.2× |
| Net cash | — | $120.7M |
| Dividend yield | — | — |
| Volatility (60d) | — | 47.8% |
| Short % of float | 2.3% | 5.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).